Results 111 to 120 of about 18,344 (221)

Targeting beta-2 adrenergic receptor attenuates schizophrenia-like behavioral effects induced by ketamine in mice: cAMP/PKA/BDNF-PEA-3 and RIM-1α signaling pathways involvement

Saudi Pharmaceutical Journal
The interplay between cAMP/PKA and neuroplasticity involves intricate signaling pathways that are crucial for brain function and are frequently disrupted in schizophrenia.
Mohammed M. Heikal, Ahmed F. Mohamed, Nora O. Abdel Rasheed, Dalia M. El-Tanbouly, Noha N. Nassar   +4 more
doaj   +1 more source

Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: A randomised controlled exploratory study [PDF]

, 2017
Brindle, Kayleigh, Crooks, Michael G., Fraser, Simon D., Hart, Simon P., Morice, Alyn H., Wright, Caroline E.   +5 more
core   +2 more sources

Formoterol dynamically alters endocannabinoid tone in the periaqueductal gray inducing headache

The Journal of Headache and Pain
Background Headache is a pain disorder present in populations world-wide with a higher incidence in females. Specifically, the incidences of medication overuse headache (MOH) have increased worldwide.
Ingrid L. Peterson, Erika Liktor-Busa, Kelly L. Karlage, Sally J. Young, Natalie E. Scholpa, Rick G. Schnellmann, Tally M. Largent-Milnes   +6 more
doaj   +1 more source

Formoterol Reduces the Pro‐Inflammatory Phenotype by Enhancing the Activity of Glutaminase in Monocyte‐Derived Macrophages in the CVB3‐Induced Viral Myocarditis

Immunity, Inflammation and Disease
Background Viral myocarditis (VMC) plays a significant role in heart failure, and there is currently a shortage of available targeted treatments. Macrophage phenotype and function are closely associated with the beta‐2 adrenergic receptor (β2‐AR). Method
Quan‐liang Li, Hua‐bao Xie, Ying‐xin Guo, Juan‐fen Li, Jing Qian, Wei‐Feng Wu   +5 more
doaj   +1 more source

Formoterol [PDF]

, 2020
openaire   +1 more source

Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist

International Journal of COPD, 2017
Hsi-Hsing Yang,1,2 Chih-Cheng Lai,3 Ya-Hui Wang,4 Wei-Chih Yang,5 Cheng-Yi Wang,4,* Hao-Chien Wang,6,* Likwang Chen,5 Chong-Jen Yu6 On behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) 1Department of Intensive Care Medicine ...
Yang HH, Lai CC, Wang YH, Yang WC, Wang CY, Wang HC, Chen L, Yu CJ   +7 more
doaj  

Treatment of bronchial asthma - A simplified overview. [PDF]

Lung India
Harvanová G, Duranková S.
europepmc   +1 more source

Evaluating Arrhythmia Risk in Patients with Chronic Obstructive Pulmonary Disease Treated with Aclidinium/Formoterol Fumarate and Other Inhaled Bronchodilators: A Post-Authorization Safety Study. [PDF]

Int J Chron Obstruct Pulmon Dis
Rebordosa C, Aguado J, Bartsch J, Saigi-Morgui N, Carsin AE, Garcia-Esteban R, Ignatova E, Freedman D, Perez-Gutthann S, Rivero-Ferrer E.   +9 more
europepmc   +1 more source

Cardiac disorders associated with compound long-acting bronchodilators for inhalation: a pharmacovigilance analysis of the FDA adverse event reporting system database. [PDF]

Front Cardiovasc Med
Lan Y, Hu D, Huang S, Xu M, He Q.
europepmc   +1 more source

Systematic review on inhaled corticosteroid monotherapy and its efficacy and safety in longterm treatment of patients with chronic obstructive pulmonary disease (COPD) [PDF]

--chronic obstructive pulmonary disease,COPD,corticosteroids,systematic review,chronisch obstruktive Lungenerkrankung,COPD,Kortikosteroid,systematischer ...
Buchberger, Barbara, Kossmann, Beate, Neumann, Anja, Niebuhr, Dea, Wasem, Jürgen   +4 more
core